Skip to main content
Erschienen in: Clinical Rheumatology 9/2015

01.09.2015 | Original Article

Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease

verfasst von: Xiao-Min Dai, Lei Wei, Li-Li Ma, Hui-Yong Chen, Zhuo-Jun Zhang, Zong-Fei Ji, Wan-Long Wu, Ling-Ying Ma, Xiu-Fang Kong, Lin-Di Jiang

Erschienen in: Clinical Rheumatology | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of coronary artery disease (CAD) is growing in the young population. We aimed to investigate the association between serum uric acid (SUA) levels and cardiovascular involvement in individuals under 45 years old diagnosed with early-onset CAD (EOCAD). Seven hundred eighty-six EOCAD patients were recruited and stratified into four groups by SUA levels. General information, serum indicators, and results of coronary angiography and echocardiography were recorded. The associations between SUA levels were explored by univariate and multivariate logistic regressions. With the increasing of SUA levels, the prevalence of hypertension and hyperlipidemia, triple branches involved, heart failure, and cardiac enlargement of left ventricle (LV), left atrium (LA), and right ventricle (RV) were significantly higher (all P < 0.05). The fourth group (SUA >8 mg/dl) had the highest proportions than other groups (all P < 0.05). After controlling potential confounders, multiple logistic regression analysis showed that odds ratios of SUA >8 mg/dl were 2.345 for triple branches involved (95 % confidence interval (CI) 1.335–4.119), 4.168 for heart failure (95 % CI 1.599–10.862), and 4.122 for LV enlargement (95 % CI 1.874–9.065) (P < 0.05). SUA >8 mg/dl was independently associated with triple branches involvement, heart failure and LV enlargement in Chinese EOCAD patients. Higher SUA level might play an important role in cardiac dysfunction and severity of EOCAD.
Literatur
1.
Zurück zum Zitat Vaisi-Raygani A, Ghaneialvar H, Rahimi Z et al (2010) The angiotensin converting enzyme Dallele is an independent risk factor for early onset coronary artery disease. Clin Biochem 43:1189–1194CrossRefPubMed Vaisi-Raygani A, Ghaneialvar H, Rahimi Z et al (2010) The angiotensin converting enzyme Dallele is an independent risk factor for early onset coronary artery disease. Clin Biochem 43:1189–1194CrossRefPubMed
2.
Zurück zum Zitat Hata J, Kiyohara Y (2013) Epidemiology of stroke and coronary artery disease in Asia. Circ J 77:1923–1932CrossRefPubMed Hata J, Kiyohara Y (2013) Epidemiology of stroke and coronary artery disease in Asia. Circ J 77:1923–1932CrossRefPubMed
3.
Zurück zum Zitat Che J, Li G, Shao Y, Niu H, Shi Y (2013) An analysis of the risk factors for premature coronary artery disease in young and middle-age Chinese patients with hypertension. Exp Clin Cardiol 18:89–92PubMedCentralPubMed Che J, Li G, Shao Y, Niu H, Shi Y (2013) An analysis of the risk factors for premature coronary artery disease in young and middle-age Chinese patients with hypertension. Exp Clin Cardiol 18:89–92PubMedCentralPubMed
4.
Zurück zum Zitat Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 33:213–220CrossRefPubMed Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 33:213–220CrossRefPubMed
5.
Zurück zum Zitat Sharma M, Ganguly NK (2005) Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag 1:217–225PubMedCentralPubMed Sharma M, Ganguly NK (2005) Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag 1:217–225PubMedCentralPubMed
6.
Zurück zum Zitat Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Völler H (2012) Disparity in risk factor pattern in premature versus late onset coronary artery disease: a survey of 15,381 patients. Vasc Health Risk Manag 8:473–481PubMedCentralCrossRefPubMed Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Völler H (2012) Disparity in risk factor pattern in premature versus late onset coronary artery disease: a survey of 15,381 patients. Vasc Health Risk Manag 8:473–481PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Fang J, Aldeman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES Iepidemiologic follow-up study, 1971-1992. JAMA 283:2404–2410CrossRefPubMed Fang J, Aldeman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES Iepidemiologic follow-up study, 1971-1992. JAMA 283:2404–2410CrossRefPubMed
8.
Zurück zum Zitat Okura T, Hiqaki J, Kurata M et al (2009) Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 73:885–891CrossRefPubMed Okura T, Hiqaki J, Kurata M et al (2009) Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 73:885–891CrossRefPubMed
9.
Zurück zum Zitat Duran M, Kalay N, Akpek M et al (2012) High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology 63:448–452CrossRefPubMed Duran M, Kalay N, Akpek M et al (2012) High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology 63:448–452CrossRefPubMed
10.
Zurück zum Zitat Li YH, Lin GM, Lin CL, Wang JH, Chen YJ, Han CL (2013) Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: a report from the ET-CHD registry, 1997-2006. J Cardiol 62:354–360CrossRefPubMed Li YH, Lin GM, Lin CL, Wang JH, Chen YJ, Han CL (2013) Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: a report from the ET-CHD registry, 1997-2006. J Cardiol 62:354–360CrossRefPubMed
11.
Zurück zum Zitat Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766CrossRefPubMed Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766CrossRefPubMed
12.
Zurück zum Zitat Papežíková I, Pekarová M, Kolářová H et al (2013) Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res 47:82–88CrossRefPubMed Papežíková I, Pekarová M, Kolářová H et al (2013) Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res 47:82–88CrossRefPubMed
13.
Zurück zum Zitat Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742CrossRefPubMed Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742CrossRefPubMed
14.
Zurück zum Zitat Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A (2012) Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol 59:235–242CrossRefPubMed Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A (2012) Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol 59:235–242CrossRefPubMed
15.
Zurück zum Zitat Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 26:269–275CrossRefPubMed Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 26:269–275CrossRefPubMed
16.
Zurück zum Zitat Kang DH, Han L, Quyang X et al (2005) Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 25:425–433CrossRefPubMed Kang DH, Han L, Quyang X et al (2005) Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 25:425–433CrossRefPubMed
17.
Zurück zum Zitat Jin M, Yang F, Yang I et al (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci 17:656–669CrossRef Jin M, Yang F, Yang I et al (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci 17:656–669CrossRef
18.
Zurück zum Zitat Baldwin W, McRae S, Marek G et al (2011) Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 60:1258–1269PubMedCentralCrossRefPubMed Baldwin W, McRae S, Marek G et al (2011) Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 60:1258–1269PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Wang H, Jacobs DR Jr, Gaffo AL, Gross MD, Goff DC Jr, Carr JJ (2013) Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Int Med 274:594–609CrossRef Wang H, Jacobs DR Jr, Gaffo AL, Gross MD, Goff DC Jr, Carr JJ (2013) Longitudinal association between serum urate and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Int Med 274:594–609CrossRef
20.
Zurück zum Zitat Maynard C, Fisher LD, Passamani ER, Pullum T (1986) Blacks in the coronary artery surgery study: risk factors and coronary artery disease. Circulation 74:64–71CrossRefPubMed Maynard C, Fisher LD, Passamani ER, Pullum T (1986) Blacks in the coronary artery surgery study: risk factors and coronary artery disease. Circulation 74:64–71CrossRefPubMed
21.
Zurück zum Zitat Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7–13CrossRefPubMed Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7–13CrossRefPubMed
22.
Zurück zum Zitat Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD (2000) Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10:136–143CrossRefPubMed Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD (2000) Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10:136–143CrossRefPubMed
23.
Zurück zum Zitat Wheeler JG, Juzwishin KD, Einksdottir G, Gudnason V, Danesh J (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2:e76PubMedCentralCrossRefPubMed Wheeler JG, Juzwishin KD, Einksdottir G, Gudnason V, Danesh J (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2:e76PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Facchini F, Chen YD, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008–3011CrossRefPubMed Facchini F, Chen YD, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008–3011CrossRefPubMed
25.
Zurück zum Zitat Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O (2012) Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 176:108–116CrossRefPubMed Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O (2012) Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 176:108–116CrossRefPubMed
26.
Zurück zum Zitat Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44:527–536CrossRefPubMed Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44:527–536CrossRefPubMed
27.
Zurück zum Zitat Lyngdoh T, Marques-Vidal P, Paccaud F et al (2011) Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One 6:e19901PubMedCentralCrossRefPubMed Lyngdoh T, Marques-Vidal P, Paccaud F et al (2011) Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One 6:e19901PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Onat A, Can G, Ornek E (2013) Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease. Clin Rheumatol 32:1767–1775CrossRefPubMed Onat A, Can G, Ornek E (2013) Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease. Clin Rheumatol 32:1767–1775CrossRefPubMed
29.
Zurück zum Zitat Kawamoto R, Tabara Y, Kohara K (2014) Interaction between serum uric acid and triglycerides in relation to prehypertension in community-dwelling Japanese adults. Clin Exp Hypertens 36:64–69CrossRefPubMed Kawamoto R, Tabara Y, Kohara K (2014) Interaction between serum uric acid and triglycerides in relation to prehypertension in community-dwelling Japanese adults. Clin Exp Hypertens 36:64–69CrossRefPubMed
30.
Zurück zum Zitat Liu Y, Jin C, Xing A et al (2013) Serum uric acid levels and the risk of impaired fasting glucose: a prospective study in adults of North China. PLoS One 8:e84712PubMedCentralCrossRefPubMed Liu Y, Jin C, Xing A et al (2013) Serum uric acid levels and the risk of impaired fasting glucose: a prospective study in adults of North China. PLoS One 8:e84712PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Demirkol S, Balta S, Cakar M, Kurt O, Dinc M (2013) Is there any correlation between serum uric acid levels and right ventricular function parameters in patients with cardiovascular risk factors? Int J Cardiol 168:3086CrossRefPubMed Demirkol S, Balta S, Cakar M, Kurt O, Dinc M (2013) Is there any correlation between serum uric acid levels and right ventricular function parameters in patients with cardiovascular risk factors? Int J Cardiol 168:3086CrossRefPubMed
32.
Zurück zum Zitat Krishnan E, Hariri A, Dabbous O, Pandya BJ (2012) Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congestive Heart Fail 18:138–143CrossRef Krishnan E, Hariri A, Dabbous O, Pandya BJ (2012) Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congestive Heart Fail 18:138–143CrossRef
33.
Zurück zum Zitat Chao TF, Hung CL, Chen SJ et al (2013) The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4027–4032CrossRefPubMed Chao TF, Hung CL, Chen SJ et al (2013) The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4027–4032CrossRefPubMed
34.
Zurück zum Zitat Marijana T, Branislava I, Cesare C (2013) Metabolic syndrome and right ventricle: an updated review. Eur J Intern Med 24:608–616CrossRef Marijana T, Branislava I, Cesare C (2013) Metabolic syndrome and right ventricle: an updated review. Eur J Intern Med 24:608–616CrossRef
35.
Zurück zum Zitat Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology 52:127–134CrossRefPubMed Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology 52:127–134CrossRefPubMed
36.
Zurück zum Zitat Yamanaka H (2011) Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 30:1018–1029CrossRefPubMed Yamanaka H (2011) Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 30:1018–1029CrossRefPubMed
Metadaten
Titel
Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease
verfasst von
Xiao-Min Dai
Lei Wei
Li-Li Ma
Hui-Yong Chen
Zhuo-Jun Zhang
Zong-Fei Ji
Wan-Long Wu
Ling-Ying Ma
Xiu-Fang Kong
Lin-Di Jiang
Publikationsdatum
01.09.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 9/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2878-1

Weitere Artikel der Ausgabe 9/2015

Clinical Rheumatology 9/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.